Skip to main page content

Retina Free Papers

My Session Status

When:
1:30 PM, Sunday 3 Jun 2018 (1 hour 30 minutes)
Breaks:
Break   03:00 PM to 03:45 PM (45 minutes)
Theme:
Retina
LEARNING OBJECTIVES
After this session, participants will be able to:
  • Describe the neurodevelopmental outcomes of babies treated with anti-VEGF for retinopathy of prematurity
  • Assess the importance of time-to-treatment for tele-retina referral programs

CANMEDS ROLES: Health Advocate, Scholar

Sub Sessions

1:30 PM - 1:35 PM | 5 minutes
1:35 PM - 1:50 PM | 15 minutes
Keynote Speaker
1:50 PM - 2:00 PM | 10 minutes

Authors: Crystal Cheung, Joshua Manusow, Efrem Mandelcorn Author Disclosure Block: C. Cheung: None. J. Manusow: None. E. Mandelcorn: None. Abstract Body: Purpose: This study sought to prospectively review the quality of ocular candida consultations by other medical services at teaching hospitals at the University of Toronto Hospital Network. Secondary endpoints of this study included: 1) Predictive characteristics of positive ocular exams...

2:00 PM - 2:10 PM | 10 minutes

Authors: Anna Ells, April Ingram, Alexander Platt, Patrick Mitchell Author Disclosure Block: A. Ells: None. A. Ingram: None. A. Platt: None. P. Mitchell: None. Abstract Body: Purpose: Intravitreal anti-VEGF therapy for treatment of severe retinopathy of prematurity (ROP) has demonstrated promising results, however reports of the safety of this treatment, related to neurodevelopmental development are limited. We compared the neurodevelopme...

Anna Ells

Participant
2:10 PM - 2:20 PM | 10 minutes

Authors: Avner Hostovsky, Rajeev H. Muni, Kenneth T. Eng, Drew Drew Mulhall, Christina Leung, Peter J. Kertes Author Disclosure Block: A. Hostovsky: None. R.H. Muni: Grant/research support; Allergan. Membership on an advisory panel, standing committee or board of directors; Allergan. K.T. Eng: None. D. Drew Mulhall: None. C. Leung: None. P.J. Kertes: Grant/research support; Allergan, Bayer, Genentech, Janssen, Novartis, Regeneron, Roche. Employment/honoraria/consultin...

2:20 PM - 2:30 PM | 10 minutes

Authors: David Plemel, Steven Lapere, Jaspreet Rayat, Donna Bong, Deana Breum, Rizwan Somani Author Disclosure Block: D. Plemel: None. S. Lapere: None. J. Rayat: None. D. Bong: None. D. Breum: None. R. Somani: None. Abstract Body: Purpose: To determine the association between ocular dimensions and sutureless scleral fixated intraocular lens (SFIOL) position with visual acuity outcomes and postoperative complications. Study Desi...

2:30 PM - 2:40 PM | 10 minutes

Authors: Carolina L. M. Francisconi, Roxane J. Hillier, Tina Felfeli, Louis R. Giavedoni, David T. Wong, Alan R. Berger, Filiberto Altomare, Rahda P. Kohly, Rajeev H. Muni Author Disclosure Block: C.L.M. Francisconi: None. R.J. Hillier: None. T. Felfeli: None. L.R. Giavedoni: None. D.T. Wong: None. A.R. Berger: None. F. Altomare: None. R.P. Kohly: None. R.H. Muni: None. Abstract Body: Purpose: The management of rhegmatogenous retinal deta...

2:40 PM - 2:50 PM | 10 minutes

Authors: Samir Nazarali, Irfan Kherani, Bernard Hurley, Geoff Williams, Michael Fielden, Feisal Adatia, Amin Kherani Author Disclosure Block: S. Nazarali: None. I. Kherani: None. B. Hurley: None. G. Williams: None. M. Fielden: None. F. Adatia: None. A. Kherani: None. Abstract Body: Purpose: To characterize the presentation of Terson Syndrome (TS) and report on the outcomes of vitrectomy at two major ophthalmic centres in Canada. TS is def...

My Session Status

Send Feedback

Session detail
Allows attendees to send short textual feedback to the organizer for a session. This is only sent to the organizer and not the speakers.
To respect data privacy rules, this option only displays profiles of attendees who have chosen to share their profile information publicly.

Changes here will affect all session detail pages